Trials / Completed
CompletedNCT03796728
A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation
LIPS: A Prospective, Open-label Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, multi-center, study where eligible participants will undergo treatment with Juvéderm® VOLIFT™ with Lidocaine injected into the lips for lip augmentation.
Detailed description
This is a prospective, open-label, multi-center, interventional, medical device, post-marketing study. Each participant will act as his/her own control. Eligible participants will undergo treatment with Juvéderm® VOLIFT™ with Lidocaine injected into the lips for lip augmentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Juvéderm® VOLIFT™ with Lidocaine | Injectable gel that is a sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, homogeneous gel implant (dermal filler). |
Timeline
- Start date
- 2018-12-19
- Primary completion
- 2020-06-09
- Completion
- 2020-06-09
- First posted
- 2019-01-08
- Last updated
- 2021-07-28
- Results posted
- 2021-07-28
Locations
4 sites across 2 countries: Portugal, United Kingdom
Source: ClinicalTrials.gov record NCT03796728. Inclusion in this directory is not an endorsement.